TRIP.COM-S
09961
MEITUAN-W
03690
NTES-S
09999
TME-SW
01698
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | 142.23%341.3M | -7.72%102.8M | 35.61%140.9M | 152.06%111.4M | -46.68%103.9M | 53.46%44.2M | 56.47%194.85M | 101.34%28.8M | 424.29%124.53M | -31.99%14.3M |
Accounts receivable | -67.85%78.5M | -43.97%93.4M | 19.02%244.2M | -15.22%166.7M | 1,084.17%205.18M | 155.90%196.62M | -38.42%17.33M | 249.48%76.83M | 8.24%28.14M | -32.88%21.99M |
Withholding and tax receivable | ---- | ---- | ---- | ---- | ---- | -85.98%196K | 497.14%209K | 3,309.76%1.4M | -39.66%35K | -37.88%41K |
Cash and equivalents | -24.15%613.1M | -6.41%796.6M | 15.46%808.3M | 71.98%851.2M | 104.89%700.05M | -22.77%494.96M | -47.92%341.66M | -16.94%640.92M | -22.81%655.98M | -16.89%771.66M |
Financial assets at fair value-current assets | -39.71%28.7M | -36.49%35.5M | -11.91%47.6M | -31.43%55.9M | -22.28%54.04M | 10.04%81.53M | --69.53M | -38.31%74.09M | ---- | --120.1M |
Derivative financial instruments-current assets | --800K | ---- | ---- | ---- | -67.46%1.73M | ---- | --5.32M | ---- | ---- | ---- |
Special items of current assets | ---- | ---- | ---- | ---- | 2.08%65.28M | -3.66%66.08M | --63.95M | --68.59M | ---- | ---- |
Total current assets | -14.39%1.06B | -13.24%1.03B | 9.81%1.24B | 34.14%1.19B | 63.12%1.13B | -0.79%883.57M | -22.29%692.85M | -4.04%890.63M | -14.20%891.61M | -12.67%928.09M |
Non-current assets | ||||||||||
Property, plant and equipment | -35.32%550M | -56.54%418M | 4.81%850.4M | 13.73%961.7M | 508.62%811.4M | 1,260.60%845.61M | 298.19%133.32M | 117.77%62.15M | -8.03%33.48M | -13.02%28.54M |
Investment property | -3.47%211.6M | --218.5M | --219.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Advance payment | 61.01%25.6M | 37.50%24.2M | 13.93%15.9M | 182.96%17.6M | -89.38%13.96M | 44.11%6.22M | 1,624.08%131.41M | -60.44%4.32M | -45.67%7.62M | -29.43%10.91M |
Interests in Joint Venture | 0.00%900K | 0.00%900K | -3.43%900K | -3.85%900K | -0.53%932K | -0.53%936K | -85.08%937K | -88.01%941K | -34.97%6.28M | -38.81%7.85M |
Other investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -47.72%10.6M | ---- |
Intangible assets | --2.7M | --2.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of non-current assets | ---- | --8.4M | ---- | ---- | ---- | ---- | ---- | -39.20%63.13M | -95.78%99.4M | -95.59%103.84M |
Total non-current assets | -27.21%790.8M | -31.40%672.4M | 31.48%1.09B | 14.94%980.2M | 210.99%826.29M | 553.25%852.78M | 68.82%265.7M | -21.92%130.54M | -93.54%157.38M | -93.08%167.2M |
Total assets | -20.37%1.85B | -21.46%1.7B | 18.96%2.33B | 24.71%2.17B | 104.11%1.96B | 70.04%1.74B | -8.62%958.54M | -6.77%1.02B | -69.83%1.05B | -68.53%1.1B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | ---- | -30.46%164.8M | 136.27%294.2M | 93.41%237M | 86.02%124.52M | 73.87%122.54M | -1.73%66.94M | 9.70%70.48M | -13.53%68.12M | -30.96%64.25M |
Tax payable | -53.92%4.7M | --2.6M | 880.77%10.2M | ---- | -0.86%1.04M | 0.00%1.04M | --1.05M | --1.04M | ---- | ---- |
Other payables and accrued expenses | --367.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Bank loans and overdrafts | ---- | ---- | ---- | ---- | ---- | ---- | --38M | 1,256.86%143.07M | ---- | --10.54M |
Other loans-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.06%113.54M | ---- |
Derivative financial instrument-current liabilities | 320.00%2.1M | -67.39%1.5M | --500K | 95.41%4.6M | ---- | -19.52%2.35M | ---- | --2.93M | --2.52M | ---- |
Provision-current liabilities | ---- | -2.50%78.1M | 20.38%79.6M | 21.33%80.1M | 211.26%66.13M | 228.18%66.02M | 94.28%21.24M | 101.82%20.12M | 83.35%10.94M | 94.27%9.97M |
Financial lease liabilities-current liabilities | -30.77%5.4M | -28.40%5.8M | -14.08%7.8M | 8.30%8.1M | 99.17%9.08M | 136.53%7.48M | 58.82%4.56M | 279.14%3.16M | 47.71%2.87M | --834K |
Special items of current liabilities | --77.8M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current liabilities | 16.65%457.6M | -23.35%252.8M | 95.40%392.3M | 65.37%329.8M | 5.65%200.76M | -17.18%199.43M | -4.02%190.03M | 181.32%240.79M | 38.03%197.98M | -44.77%85.59M |
Net current assets | -28.74%604.8M | -9.34%775.5M | -8.68%848.7M | 25.03%855.4M | 84.84%929.41M | 5.28%684.14M | -27.51%502.82M | -22.87%649.84M | -22.56%693.63M | -7.20%842.5M |
Total assets less current liabilities | -27.88%1.4B | -21.12%1.45B | 10.22%1.94B | 19.43%1.84B | 128.45%1.76B | 96.95%1.54B | -9.69%768.51M | -22.71%780.38M | -74.47%851.01M | -69.63%1.01B |
Non-current liabilities | ||||||||||
Long-term bank loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.87%3M | ---- | --141M |
Other loans-non-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -75.32%38M | ---- |
Financial lease liabilities-non-current liabilities | 10.00%19.8M | -22.86%16.2M | -26.79%18M | -10.66%21M | 183.11%24.59M | 571.00%23.51M | 93.95%8.69M | --3.5M | --4.48M | ---- |
Deferred tax liability | -29.67%30.1M | -60.37%23.7M | -29.80%42.8M | 29.38%59.8M | 222.20%60.97M | 209.79%46.22M | 30.39%18.92M | 27.40%14.92M | -64.20%14.51M | -62.75%11.71M |
Provision-non-current liabilities | ---- | -50.23%215.6M | 20.43%439.1M | 18.45%433.2M | 9,285.12%364.61M | --365.71M | -65.27%3.89M | ---- | 10.72%11.19M | 8.65%10.54M |
Special items of non-current liabilities | --196.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total non-current liabilities | -50.73%246.3M | -50.29%255.5M | 11.05%499.9M | 18.04%514M | 1,329.43%450.17M | 1,932.58%435.44M | -53.81%31.49M | -86.88%21.42M | -66.68%68.18M | -16.34%163.25M |
Total liabilities | -21.11%703.9M | -39.76%508.3M | 37.06%892.2M | 32.91%843.8M | 193.84%650.93M | 142.12%634.87M | -16.77%221.52M | 5.37%262.21M | -23.53%266.16M | -28.93%248.84M |
Total assets less total liabilities | -19.92%1.15B | -9.78%1.19B | 9.93%1.44B | 19.98%1.32B | 77.14%1.31B | 45.13%1.1B | -5.85%737.02M | -10.34%758.96M | -74.98%782.83M | -72.96%846.46M |
Total equity and non-current liabilities | -27.88%1.4B | -21.12%1.45B | 10.22%1.94B | 19.43%1.84B | 128.45%1.76B | 96.95%1.54B | -9.69%768.51M | -22.71%780.38M | -74.47%851.01M | -69.63%1.01B |
Equity | ||||||||||
Share capital | -0.23%87.4M | -0.79%87.4M | 0.01%87.6M | 0.58%88.1M | 0.00%87.59M | 0.00%87.59M | 0.00%87.59M | 0.00%87.59M | 0.00%87.59M | 0.00%87.59M |
Reserve | -21.20%1.06B | -10.42%1.11B | 10.65%1.35B | 21.66%1.23B | 87.53%1.22B | 51.01%1.01B | -6.56%649.48M | -11.51%671.42M | -77.14%695.1M | -75.06%758.71M |
Shareholders' Equity | -19.92%1.15B | -9.78%1.19B | 9.94%1.44B | 19.99%1.32B | 77.13%1.31B | 45.13%1.1B | -5.83%737.07M | -10.31%759.01M | -74.98%782.69M | -72.96%846.3M |
Non-controlling interest | 0.00%-100K | 0.00%-100K | -104.08%-100K | -104.08%-100K | -4.26%-49K | 3.92%-49K | -133.33%-47K | -132.69%-51K | -31.22%141K | -24.64%156K |
Total equity | -19.92%1.15B | -9.78%1.19B | 9.93%1.44B | 19.98%1.32B | 77.14%1.31B | 45.13%1.1B | -5.85%737.02M | -10.34%758.96M | -74.98%782.83M | -72.96%846.46M |
Total equity and total liabilities | -20.37%1.85B | -21.46%1.7B | 18.96%2.33B | 24.71%2.17B | 104.11%1.96B | 70.04%1.74B | -8.62%958.54M | -6.77%1.02B | -69.83%1.05B | -68.53%1.1B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.